China Jo-Jo Drugstores In...

NASDAQ: CJJD · Real-Time Price · USD
1.52
-0.09 (-5.59%)
At close: Mar 03, 2025, 3:58 PM

China Jo-Jo Drugstores Income Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Revenue
35.58M 35.58M 37.98M 37.98M 39.29M 39.29M 38.04M 38.04M 36.36M 36.36M 85.91M 42.95M 78.48M 39.24M 35.7M 35.54M 30.84M 31.05M
Cost of Revenue
28.28M 28.28M 30.4M 30.4M 31.32M 31.32M 29.37M 29.37M 27.9M 27.9M 64.79M 32.39M 63.09M 31.54M 29.54M 27.45M 23.83M 23.07M
Gross Profit
7.3M 7.3M 7.59M 7.59M 7.97M 7.97M 8.68M 8.68M 8.46M 8.46M 21.12M 10.56M 15.4M 7.7M 6.16M 8.09M 7.01M 7.98M
Operating Income
-1.11M -1.11M -1.9M -1.9M 127.99K 127.99K -9.84M -9.84M -622.34K -622.34K -2.05M -1.03M -492.31K -246.16K 153.51K -6.37M -1.52M -198.75K
Interest Income
n/a n/a 299.75K 143.22K n/a n/a 366.66K 366.66K 42.37K 42.37K 93.1K 93.1K 23.25K 23.25K 163.42K 193.21K 187.67K 163.59K
Pretax Income
-1.13M -1.13M -1.64M -1.64M -442.55K -442.55K -10.29M -10.29M -78.12K -78.12K -1.83M -917.36K -263.92K -131.96K -175.21K -6.29M -1.55M -331.02K
Net Income
-1.14M -1.14M -1.65M -1.65M -462.12K -462.12K -10.27M -10.27M -297.39K -297.39K -2.93M -1.46M -262.74K -131.37K -166.28K -6.29M -1.53M -388.59K
Selling & General & Admin
8.41M 8.41M 9.48M 9.48M 7.84M 7.84M 18.52M 18.52M 9.08M 9.08M 23.17M 11.59M 15.89M 7.95M 6.47M 14.45M 8.54M 8.39M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 148.79K n/a n/a n/a n/a -43.52K n/a 50.02K
Operating Expenses
8.41M 8.41M 9.37M 9.37M 8.52M 8.52M 19.34M 19.34M 8.58M 8.58M 23.17M 11.57M 15.89M 7.81M 6.47M 14.45M 8.54M 8.39M
Interest Expense
n/a n/a 13.3K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 100.21K 109.9K 117.69K 127.39K
Selling & Marketing Expenses
7.05M 7.05M 2.93M 2.93M 7.02M 7.02M 7.32M 7.32M 7.27M 7.27M 8.79M 8.79M 6.65M 6.65M 5.94M 8.26M 6.48M 6.27M
Cost & Expenses
36.69M 36.69M 39.77M 39.77M 39.84M 39.84M 48.71M 48.71M 36.48M 36.48M 87.96M 43.96M 78.98M 39.35M 36M 41.91M 32.37M 31.47M
Income Tax Expense
5.3K 5.3K 11.85K 11.85K 19.59K 19.59K 22.12K 22.12K 219.39K 219.39K 1.1M 547.9K 3.93K 1.96K -8.93K 1.98K -18.98K 57.57K
Shares Outstanding (Basic)
5.38M 5.38M 1.69M 1.69M 1.2M 1.2M 792.95K 792.95K 226.7K 226.7K 14.5K 173.97K 173.97K 109.48K 3.48M 3.44M 3.11M 2.87M
Shares Outstanding (Diluted)
5.38M 5.38M 1.69M 1.69M 1.2M 1.2M 792.95K 792.95K 226.7K 226.7K 200.33K 173.97K 173.97K 173.97K 3.48M 3.44M 3.16M 2.87M
EPS (Basic)
-0.21 -0.21 -0.98 -0.98 -0.39 -0.39 -12.95 -12.95 -1.31 -1.31 -202.07 -8.42 -1.51 -1.2 -0.05 -1.83 -0.49 -0.14
EPS (Diluted)
-0.21 -0.21 -0.98 -0.98 -0.39 -0.39 -12.95 -12.95 -1.31 -1.31 -14.62 -8.42 -1.51 -0.76 -0.05 -1.83 -0.48 -0.14
EBITDA
-860.88K -860.88K -1.67M -1.67M 288.47K 288.47K -9.81M -9.81M -307.07K -307.07K -1.47M -762.03K 180.52K 90.26K 80.67K -5.78M -930.86K 556.9K
EBIT
-1.11M -1.11M -1.63M -1.9M 127.99K 127.99K -9.84M -9.84M -622.34K -622.34K -1.51M -1.03M -492.31K -246.16K -75K -6.18M -1.43M -203.63K
Depreciation & Amortization
250.48K 250.48K 225.5K 225.5K 160.48K 160.48K 34.07K 34.07K 315.27K 315.27K 583.67K 264.36K 672.83K 336.41K 155.67K 398.85K 497.62K 760.54K